BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16599260)

  • 1. Development and in vitro/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy.
    Ikinci G; Senel S; Tokgözoğlu L; Wilson CG; Sumnu M
    Pharmazie; 2006 Mar; 61(3):203-7. PubMed ID: 16599260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation.
    Ikinci G; Senel S; Wilson CG; Sumnu M
    Int J Pharm; 2004 Jun; 277(1-2):173-8. PubMed ID: 15158980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy.
    Park CR; Munday DL
    Int J Pharm; 2002 Apr; 237(1-2):215-26. PubMed ID: 11955819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of nicotine patches in breast-feeding mothers: transfer of nicotine and cotinine into human milk.
    Ilett KF; Hale TW; Page-Sharp M; Kristensen JH; Kohan R; Hackett LP
    Clin Pharmacol Ther; 2003 Dec; 74(6):516-24. PubMed ID: 14663454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
    Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
    Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of serum nicotine and plasma cotinine concentrations to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy.
    Lawson GM; Hurt RD; Dale LC; Offord KP; Croghan IT; Schroeder DR; Jiang NS
    J Clin Pharmacol; 1998 Jun; 38(6):502-9. PubMed ID: 9650539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of a buccal bioadhesive system for smoking cessation therapy.
    Garg S; Kumar G
    Pharmazie; 2007 Apr; 62(4):266-72. PubMed ID: 17484281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose nicotine patch therapy for smokers with a history of alcohol dependence: 36-week outcomes.
    Kalman D; Kahler CW; Garvey AJ; Monti PM
    J Subst Abuse Treat; 2006 Apr; 30(3):213-7. PubMed ID: 16616165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine.
    Ikinci G; Capan Y; Senel S; Alaaddinoğlu E; Dalkara T; Hincal AA
    Pharmazie; 2000 Oct; 55(10):762-5. PubMed ID: 11082839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.
    Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI
    Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biorelevant in vitro release/permeation system for oral transmucosal dosage forms.
    Delvadia PR; Barr WH; Karnes HT
    Int J Pharm; 2012 Jul; 430(1-2):104-13. PubMed ID: 22486954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
    Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
    Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
    Berlin I; Jacob N; Coudert M; Perriot J; Schultz L; Rodon N
    Addiction; 2011 Apr; 106(4):833-43. PubMed ID: 21205047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets.
    Pongjanyakul T; Kanjanabat S
    AAPS PharmSciTech; 2012 Jun; 13(2):674-85. PubMed ID: 22552930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid absorption of nicotine from new nicotine gum formulations.
    Shiffman S; Cone EJ; Buchhalter AR; Henningfield JE; Rohay JM; Gitchell JG; Pinney JM; Chau T
    Pharmacol Biochem Behav; 2009 Jan; 91(3):380-4. PubMed ID: 18762208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure to high ambient temperature increases absorption and plasma concentrations of transdermal nicotine.
    Vanakoski J; Seppälä T; Sievi E; Lunell E
    Clin Pharmacol Ther; 1996 Sep; 60(3):308-15. PubMed ID: 8841153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
    Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
    Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City.
    Calderón-Ezquerro C; Sánchez-Reyes A; Sansores RH; Villalobos-Pietrini R; Amador-Muñoz O; Guerrero-Guerra C; Calderón-Segura ME; Uribe-Hernández R; Gómez-Arroyo S
    Hum Exp Toxicol; 2007 Sep; 26(9):715-22. PubMed ID: 17984142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.